Core Insights - Visionary Holdings Inc. announced progress in executing a commercial sales agreement valued at approximately US$9 million through its subsidiary, Visionary Health Technology Group Limited [1][2] - The agreement, signed in September 2025, is currently in the implementation stage with service activities underway [2][3] - The company expects to achieve further substantive execution milestones by the end of the first quarter of 2026 based on the current delivery schedule [3] Agreement Details - The commercial scope of the agreement includes the Premier Regenerative Complex product series and customized VIP health services [4] - These services are tailored based on individual health assessments and delivered within a structured medical oversight framework [4] Management Commentary - The CEO of Visionary Holdings emphasized the importance of converting strategic partnerships into operational results and highlighted the potential for revenue growth and margin improvement from this business segment [5] Company Overview - Visionary Holdings Inc. is a technology-driven multinational enterprise focused on innovative education, AI applications, and high-tech healthcare solutions, operating across North America and Asia [6]
Visionary Holdings Announces Continued Progress of Approximately US$9 Million Sales Contract